6WX2
Vaccine-elicited mouse FP-targeting neutralizing antibody vFP16.02 with F60P mutation on light chain in complex with HIV fusion peptide (residue 512-519)
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | APS BEAMLINE 22-ID |
| Synchrotron site | APS |
| Beamline | 22-ID |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2019-10-02 |
| Detector | DECTRIS EIGER X 16M |
| Wavelength(s) | 1 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 73.246, 111.697, 123.804 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 35.650 - 2.390 |
| R-factor | 0.2027 |
| Rwork | 0.200 |
| R-free | 0.25020 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 6cdo |
| Data reduction software | HKL-2000 |
| Data scaling software | HKL-2000 |
| Phasing software | PHASER |
| Refinement software | PHENIX (1.18_3861) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 50.000 | 50.000 | 2.440 |
| High resolution limit [Å] | 2.390 | 6.510 | 2.400 |
| Rmerge | 0.155 | 0.073 | 0.806 |
| Rmeas | 0.162 | 0.076 | 0.852 |
| Rpim | 0.048 | 0.022 | 0.269 |
| Number of reflections | 39911 | 2156 | 1947 |
| <I/σ(I)> | 6.4 | ||
| Completeness [%] | 99.6 | 98.8 | 99.5 |
| Redundancy | 11 | 11.2 | 9.5 |
| CC(1/2) | 0.998 | 0.913 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 293 | 9.9% v/v isopropanol, 0.1 M Tris-HCl, pH 8.5, 9.9% v/v PEG3350 |






